Citations

Clear

4847 citation(s) found for "Tu, Eric".

Vascular masking for improved unfolding in 2D SENSE-accelerated 3D contrast-enhanced MR angiography
Stinson, Eric G. , Borisch, Eric A. , Johnson, Casey P. , Trzasko, Joshua D. , Young, Phillip M. , Riederer, Stephen J.

Mayo Clinic

Journal of Magnetic Resonance Imaging | July 29, 2013 | Volume: 39 | Issue: 5 | Pages: 1161-1170

10.1002/jmri.24266 | PMID 23897776 Get It

Automatic Selection of Tube Potential for Radiation Dose Reduction in Vascular and Contrast-Enhanced Abdominopelvic CT
Yu, Lifeng , Grant, Katharine L., Carter, Rickey E. , Hough, David M., Barlow, John M. , Vrtiska, Terri J., Williamson, Eric E. , Young, Phillip M. , Goss, Brian C., Shiung, Maria, Raupach, Ranier, Schmidt, Bernhard , Flohr, Thomas , Yu, Lifeng , Fletcher, Joel G. , Leng, Shuai , McCollough, Cynthia H. , Carter, Rickey E

Mayo Clinic

American Journal of Roentgenology | July 24, 2013 | Volume: 201 | Issue: 2 | Pages: W297-W306

10.2214/ajr.12.9610 | PMID 23883244 Get It

Diaphragm depth in normal subjects
Shahgholi, Leili , Baria, Michael R. , Sorenson, Eric J. , Harper, Caitlin J., Watson, James C. , Strommen, Jeffrey A., Boon, Andrea J.

Mayo Clinic

Muscle & Nerve | July 19, 2013 | Volume: 49 | Issue: 5 | Pages: 666-668

10.1002/mus.23953 | PMID 23873396 Get It

ABSTRACTIntroduction: Needle electromyography (EMG) of the diaphragm carries the potential risk of pneumothorax. Knowing the approximate depth of the diaphragm should increase the test's safety and accuracy. Methods: Distances from the skin to the diaphragm and from the outer surface of the rib to the diaphragm were measured using B mode ultrasound in 150 normal subjects. Results: When measured at the lower intercostal spaces, diaphragm depth varied between 0.78 and 4.91 cm beneath the skin surface and between 0.25 and 1.48 cm below the outer surface of the rib. Using linear regression modeling, body mass index (BMI) could be used to predict diaphragm depth from the skin to within an average of 1.15 mm. Conclusions: Diaphragm depth from the skin can vary by more than 4 cm. When image guidance is not available to enhance accuracy and safety of diaphragm EMG, it is possible to reliably predict the depth of the diaphragm based on BMI. Muscle Nerve 49: 666–668, 2014
Provider Specialty and Atrial Fibrillation Treatment Strategies in United States Community Practice: Findings From the ORBIT‐AF Registry
Fosbøl, Emil Loldrup , Holmes, DaJuanicia N. , Piccini, Jonathan P. , Thomas, Laine , Reiffel, James A. , Mills, Roger M. , Kowey, Peter R. , Mahaffey, Kenneth W. , Patients, the ORBIT‐AF Investigators and, Gersh, Bernard J. , Peterson, Eric D. , Patients, the ORBIT‐AF Investigators and, Mills, Roger M

Mayo Clinic

Journal of the American Heart Association | July 19, 2013 | Volume: 2 | Issue: 4 | Pages: No page available

10.1161/jaha.113.000110 | PMID 23868192 Get It

Background The prevalence of atrial fibrillation ( AF ) continues to increase; however, there are limited data describing the division of care among practitioners in the community and whether care differs depending on provider specialty. Methods and Results Using the Outcomes Registry for Better Informed Treatment of AF ( ORBIT ‐ AF ) Registry, we described patient characteristics and AF management strategies in ambulatory clinic practice settings, including electrophysiology ( EP ), general cardiology, and primary care. A total of 10 097 patients were included; of these, 1544 (15.3%) were cared for by an EP provider, 6584 (65.2%) by a cardiology provider, and 1969 (19.5%) by an internal medicine/primary care provider. Compared with those patients who were cared for by cardiologists or internal medicine/primary care providers, patients cared for by EP providers were younger (median age, 73 years [interquartile range, IQR , 64, 80 years, Q1, Q3] versus 75 years [ IQR , 67, 82 years] for cardiology and versus 76 years [ IQR , 68, 82 years] for primary care). Compared with cardiology and internal medicine/primary care providers, EP providers used rhythm control (versus rate control) management more often (44.2% versus 29.7% and 28.8%, respectively, P <0.0001; adjusted odds ratio [ OR ] EP versus cardiology, 1.66 [95% confidence interval, CI , 1.05 to 2.61]; adjusted OR for internal medicine/primary care versus cardiology, 0.91 [95% CI , 0.65 to 1.26]). Use of oral anticoagulant therapy was high across all providers, although it was higher for cardiology and EP providers (overall, 76.1%; P =0.02 for difference between groups). Conclusions Our data demonstrate important differences between provider specialties, the demographics of the AF patient population treated, and treatment strategies—particularly for rhythm control and anticoagulation therapy.
Impact of radiotherapy on surgical repair and outcome in patients with rectourethral fistula
Beddy, David, Poškus, Tomas , Umbreit, Eric , Elliott, Daniel S. , Dozois, Eric J. , Larson, David W.

Mayo Clinic

Colorectal Disease | July 11, 2013 | Volume: 15 | Issue: 12 | Pages: 1515-1520

10.1111/codi.12350 | PMID 23841640 Get It

AbstractAimMost patients presenting with rectourethral fistula acquire it as a complication of radiotherapy for prostate cancer, as a result of injury to the rectum during prostatectomy, through trauma or from Crohn's disease. This study examined whether choice of operation and results of surgery for rectourethral fistula are influenced by prior radiotherapy.MethodMale patients undergoing surgery for rectourethral fistula were identified from a prospectively maintained database. Data regarding aetiology, surgical treatment and outcomes were analysed.ResultsFifty patients (median age = 65.5 years) were identified. Radiation was received by 29 patients for prostate or rectal cancer, and 21 patients developed a fistula following prostatectomy, Crohn's disease or pelvic fracture (without radiation). Prior to definitive surgery, 30 patients underwent fecal diversion and 37 underwent urinary diversion. In total, 57 repairs were performed (44 patients had one repair, five patients had two and one patient had three). Definitive surgery was approached predominantly abdominally in radiated patients (90.6 vs 9.3%, P < 0.001) and perineally in nonradiated patients (80 vs 20%, P < 0.001). Successful primary fistula repair was more frequent in the nonradiated group compared with the radiated group (80.9 vs 0%, P < 0.001). Permanent colostomy and urinary diversion were more often required in radiated patients than in nonradiated patients (colostomy: 83 vs 0%, P < 0.001; urorostomy: 100 vs 19%, P < 0.001).ConclusionFew patients with radiation‐induced rectourethral fistula avoid permanent colostomy and urostomy. In contrast, most patients with nonradiation‐related fistulae undergo successful perineal repair without permanent faecal and urinary diversion.
High-Throughput Immunoassay for the Biochemical Diagnosis of Friedreich Ataxia in Dried Blood Spots and Whole Blood
Oglesbee, Devin , Kroll, Charles, Gakh, Oleksandr , Gavrilova, Ralitza H. , Tortorelli, Silvia , Raymond, Kimiyo , Gavrilov, Dimitar , Rinaldo, Piero, Matern, Dietrich , Isaya, Grazia , Deutsch, Eric C , Lynch, David R. , Oglesbee, Devin

Mayo Clinic

Clinical Chemistry | July 10, 2013 | Volume: 59 | Issue: 10 | Pages: 1461-1469

10.1373/clinchem.2013.207472 | PMID 23838345 Get It

BACKGROUND Friedreich ataxia (FRDA) is caused by reduced frataxin (FXN) concentrations. A clinical diagnosis is typically confirmed by DNA-based assays for GAA-repeat expansions or mutations in the FXN (frataxin) gene; however, these assays are not applicable to therapeutic monitoring and population screening. To facilitate the diagnosis and monitoring of FRDA patients, we developed an immunoassay for measuring FXN. METHODS Antibody pairs were used to capture FXN and an internal control protein, ceruloplasmin (CP), in 15 μL of whole blood (WB) or one 3-mm punch of a dried blood spot (DBS). Samples were assayed on a Luminex LX200 analyzer and validated according to standard criteria. RESULTS The mean recovery of FXN from WB and DBS samples was 99%. Intraassay and interassay imprecision (CV) values were 4.9%–13% and 9.8%–16%, respectively. The FXN limit of detection was 0.07 ng/mL, and the reportable range of concentrations was 2–200 ng/mL. Reference adult and pediatric FXN concentrations ranged from 15 to 82 ng/mL (median, 33 ng/mL) for DBS and WB. The FXN concentration range was 12–22 ng/mL (median, 15 ng/mL) for FRDA carriers and 1–26 ng/mL (median 5 ng/mL) for FRDA patients. Measurement of the FXN/CP ratio increased the ability to distinguish between patients, carriers, and the reference population. CONCLUSIONS This assay is applicable to the diagnosis and therapeutic monitoring of FRDA. This assay can measure FXN and the control protein CP in both WB and DBS specimens with minimal sample requirements, creating the potential for high-throughput population screening of FRDA.
Post-lumbar puncture headache is reduced with use of atraumatic needles in ALS
Macklin, Eric A. , Atassi, Nazem , Bowser, Robert , Cudkowicz, Merit , Fournier, Christina , Ladha, Shafeeq , Lacomis, David , Quinn, Colin , Boylan, Khrista , Berry, James D. , Ladha, Shafeeq , Cudkowicz, Merit E

Mayo Clinic

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration | July 8, 2013 | Volume: 14 | Issue: 7-8 | Pages: 632-634

10.3109/21678421.2013.808227 | PMID 23834161 Get It

Brief Report: Accelerated Aging Influences Cardiovascular Disease Risk in Rheumatoid Arthritis
Crowson, Cynthia S. , Therneau, Terry M. , Davis, John M. , Roger, Véronique L. , Matteson, Eric L. , Gabriel, Sherine E., Davis, John M

Mayo Clinic

Arthritis & Rheumatism | July 1, 2013 | Volume: 65 | Issue: 10 | Pages: 2562-2566

10.1002/art.38071 | PMID 23818136 Get It

ObjectiveTo determine whether the impact of aging on cardiovascular disease (CVD) risk in patients with rheumatoid arthritis (RA) differs from that in the general population (as estimated by the Framingham Risk Score [FRS]).MethodsA population‐based inception cohort of Olmsted County, Minnesota residents ages ≥30 years who fulfilled the American College of Rheumatology 1987 criteria for RA in 1988–2008 was assembled and followed up until death, migration, or July 1, 2012. Data on CVD events were collected by medical records review. The 10‐year FRS for CVD was calculated. Cox models adjusted for FRS were used to examine the influence of age on CVD risk.ResultsThe study included 563 patients with RA without prior CVD (mean age 55 years, 72% women, and 69% seropositive [i.e., rheumatoid factor and/or anti–citrullinated protein antibody positive]). During a mean followup of 8.2 years, 98 patients developed CVD (74 seropositive and 24 seronegative), but the FRS predicted only 59.7 events (35.4 seropositive and 24.3 seronegative). The gap between observed and predicted CVD risk increased exponentially across age, and the effect of age on CVD risk in seropositive RA was nearly double its effect in the general population, with additional log(age) coefficients of 2.91 for women (P = 0.002) and 2.06 for men (P = 0.027).ConclusionOur findings indicate that age exerts an exponentially increasing effect on CVD risk in seropositive RA, but no increased effect among seronegative patients. The causes of accelerated aging in patients with seropositive RA deserve further investigation.
Idiopathic subglottic stenosis: An evolving therapeutic algorithm
Maldonado, Fabien , Loiselle, Andrea, DePew, Zachary S. , Edell, Eric S. , Ekbom, Dale C. , Malinchoc, Michael, Hagen, Clinton E., Alon, Eran E. , Kasperbauer, Jan L.

Mayo Clinic

The Laryngoscope | July 1, 2013 | Volume: 124 | Issue: 2 | Pages: 498-503

10.1002/lary.24287 | PMID 23818139 Get It